Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,774 across all filing types
Latest filing 2019-01-24 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC RECEIVES MILESTONE PAYMENT FOR START OF PHASE II CLINICAL TRIAL
Regulatory Filings Classification · 100% confidence The document is a press release dated January 24, 2019, announcing that Evotec AG received a milestone payment from its partner, Second Genome, due to the initiation of a Phase II clinical trial for a licensed molecule (SGM-1019). This content focuses on a specific business development event (milestone payment tied to clinical trial progress) rather than a comprehensive financial report (10-K, IR), a formal earnings announcement (ER), or a general regulatory filing (RNS). Since it details a specific corporate event that is not covered by other specific codes like DIV, CAP, or M&A, it falls best under the general 'Regulatory Filings' (RNS) category as a corporate news announcement, or potentially a miscellaneous announcement if a more specific category existed. Given the options, RNS serves as the best fit for a general corporate news release about a partnership milestone that isn't a formal earnings release or a specific financial filing.
2019-01-24 English
DGAP-DD: Evotec AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of a member of the managing body (Dr. Cord Dohrmann), the nature of the transaction (Exercise against cash settlement, Transaction linked to the exercise of share option programmes), the price, volume, and date of the transaction involving Evotec AG shares. This content directly corresponds to the definition of Director's Dealing.
2019-01-23 English
DGAP-DD: Evotec AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of a member of the managing body (Dr. Werner Lanthaler), the nature of the transaction ('Purchase of shares by exercising stock options'), the date, and the price/volume. This content directly matches the definition for Director's Dealing.
2019-01-14 English
DGAP-DD: Evotec AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Dr. Werner Lanthaler), their position ('Member of the managing body'), and the specifics of a transaction involving shares, including price, volume, and date. This content directly matches the definition for Director's Dealing.
2019-01-14 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' regarding BlackRock, Inc.'s change in voting rights in Evotec AG, crossing a threshold on 04 Jan 2019. This directly corresponds to the definition of a notification of changes in significant share ownership levels, which maps to the Major Shareholding Notification code (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a detailed disclosure of shareholding changes, not the results of a vote (DVA).
2019-01-09 English
EVOTEC REACHES IMPORTANT SCIENTIFIC ACHIEVEMENT WITHIN IPSC-BASED COLLABORATION WITH CELGENE
Regulatory Filings Classification · 99% confidence The document is a press release dated January 8, 2019, announcing a scientific achievement and a corresponding payment ($14.0 M) received from Celgene under a strategic alliance. It details progress in a drug development program, specifically advancing a program into the lead optimization stage using iPSC technology. This type of announcement, focusing on partnership milestones, scientific progress, and associated payments, is typically classified as a general corporate news release or an update on strategic activities, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it details a significant business/scientific milestone and payment trigger, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, as it doesn't align perfectly with the more specific categories like DIV, CAP, or ER. Given the context of a DGAP-News transmission, RNS is the most appropriate fallback for significant, non-standard corporate news.
2019-01-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.